GUD:TSE
Knight Therapeutics Inc
CA$11.35
arrow_downward
-1.82%(-0.21) 1D
Nov 19, 12:20:22 PM GMT-5 · CAD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GUD...
Open
CA$11.58
High
CA$11.60
Low
CA$11.27
Mkt. cap
1.12B
Avg. vol.
69.41K
Volume
59.42K
P/E ratio
70.61
52-wk high
CA$12.18
52-wk low
CA$5.66
EPS
CA$0.16
Beta
-0.05
Shares outstanding
98.28M
No. of employees
830
Open
CA$11.58
High
CA$11.60
Low
CA$11.27
Mkt. cap
1.12B
Avg. vol.
69.41K
Volume
59.42K
P/E ratio
70.61
52-wk high
CA$12.18
52-wk low
CA$5.66
EPS
CA$0.16
Beta
-0.05
Shares outstanding
98.28M
No. of employees
830
News stories
From web sources and news partners
24/7 Wall St.
·
24 minutes ago
S&P 500 Drops Nearly 1% at Midday While the Dow Slides 1.5%
Investing.com
·
1 hour ago
Record-negative dealer gamma and what it means for the S&P 500
ChartMill
·
2 hours ago
S&P 500 Gap Movers: Today's Gap-Up and Gap-Down Stocks
Traders Union
·
24 minutes ago
Charlie Bilello: S&P 500 declines 8% from October peak, largest pullback since March
Profile
Knight Therapeutics Inc. is a Canadian public specialty pharmaceutical company based in Montreal, Quebec that focuses on acquiring or in-licensing innovative pharmaceutical products for the Canadian and select international markets. It is listed on the Toronto Stock Exchange, with a market capitalization of $1.02 billion as of August 2019. Wikipedia
About Knight Therapeutics Inc
CEO-
Employees830
Founded2014
HeadquartersMontreal, Quebec, Canada
SectorHealth Care
IndustryPharmaceutical industry
Websiteknighttx.com